World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

CLINICAL TRIAL TO EVALUATE THE EFFICACY OF JALA BASTI IN PROPHYLAXIS OF PREDIABETES

Dr. Praveen Singh*, Prof. Satya Manav Dayal, Dr. Mannat Marwaha

ABSTRACT

Pre-diabetes/ intermediate hyperglycaemia grounded on glycaemic variables above normal range but under diabetes thresholds. The prevalence of pre-diabetes is surging all over the world and it is estimated that >470 million people will develop pre-diabetes in 2030. Lifestyle modification is the mainspring of diabetes prevention with documentation of a 40%–70% relative risk reduction. So, open clinical trial on an Ayurvedic intervention Jala basti was planned in prophylaxis of Pre-diabetes. Aim of the trial was to evaluate the effect of Jala Basti in prophylaxis of Pre-diabetes. 40 Pre diabetic Patients who were willing for trial, aged between 20-70 years of either sex, having Hemoglobin A1C range between 5.7% to 6.4%, FBG (fasting blood glucose) range 100 mg/dl to 125 mg/dl, OGTT (Oral glucose tolerance test 2 hour blood glucose) range between 140 mg/dl to 199 mg/dl, RBS (random blood sugar level) greater than or equal to 200 mg/dl were selected from OPD and IPD of Dept. Of Swasthwrita, Hospital of Uttaranchal Ayurvedic Collage, Uttarakhand Ayurved University, Dehradun. Patients below age of 20 years and above 70 years of age, all type 1 and type 2 Diabetes mellitus cases and cases with complications of the disease or having other associated disease were excluded from trial. The assessment of relief in Blood sugar fasting, RBS, OGTT, HBA1C has been shown as 12.24%, 16.27%, 14.36% and 3.8% relief respectively. The p value for all these is

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR